16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To date, the delivery of nano-sized therapeutic agents to cancers largely relies on enhanced permeability and retention (EPR) effects that are caused by the leaky nature of cancer vasculature. However, nano-sized agents delivered in this way have demonstrated limited success in oncology due to the relatively small magnitude of the EPR effect. For achieving superior delivery of nano-sized agents, super-enhanced permeability and retention (SUPR) effects are needed. Near infrared photo-immunotherapy (NIR-PIT) is a recently reported therapy that treats tumors with light therapy and subsequently causes an increase in nano-drug delivery up to 24-fold compared with untreated tumors in which only the EPR effect is present. SUPR effects could enhance delivery into tumor beds of a wide variety of nano-sized agents including particles, antibodies, and protein binding small molecular agents. Therefore, taking advantage of the SUPR effects after NIR-PIT may be a promising avenue to utilize a wide variety of nano-drugs in a highly effective manner.

          Graphical abstract

          Related collections

          Author and article information

          Journal
          101525249
          37848
          Nanoscale
          Nanoscale
          Nanoscale
          2040-3364
          2040-3372
          5 January 2016
          07 October 2015
          07 July 2016
          07 January 2017
          : 8
          : 25
          : 12504-12509
          Affiliations
          Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States
          Author notes
          [* ]Corresponding author: Hisataka Kobayashi, M.D., Ph.D., Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, NIH, Building 10, RoomB3B69, MSC1088, Bethesda, MD 20892-1088. Phone: 301-451-4220, Fax: 301-402-3191. Kobayash@ 123456mail.nih.gov
          Article
          PMC4824660 PMC4824660 4824660 nihpa729385
          10.1039/c5nr05552k
          4824660
          26443992
          655acde2-ab0c-45ce-a492-696e983ee30d
          History
          Categories
          Article

          photoimmunotherapy,near infrared,enhanced permeability and retention effects,super-enhanced permeability and retention effects,drug delivery,cancer

          Comments

          Comment on this article